𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cell mediated immune response in the liver transplant patient with hepatitis C: Rejection vs recurrence

✍ Scribed by Mayra M. Lopez-Cepero; James Huang; James Mayes; William M. LeFor; Victor Bowers

Book ID
116531002
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
31 KB
Volume
66
Category
Article
ISSN
0198-8859

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatic stellate cell activation in live
Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C
✍ Laura Cisneros; Maria-Carlota LondoΓ±o; Carmen Blasco; RamΓ³n Bataller; Rosa Mique πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 2 views

The pathogenic mechanisms of accelerated graft fibrosis in hepatitis C recurrence after liver transplantation (LT) are not well established. The aim of the study was to assess whether a greater activation of hepatic stellate cells (HSC), the major collagen-producing cells in the liver, can occur in

Using an immune functional assay to diff
Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients
✍ Roniel Cabrera; Miguel Ararat; Consuelo Soldevila-Pico; Lisa Dixon; Jen-Jung Pan πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 139 KB

In transplant recipients transplanted for hepatitis C, presentation of abnormal transaminases can herald the presentation of recurrent hepatitis C, cellular rejection, or both. Given the sometimes ambiguous histology with these 2 entities, the ability to distinguish them is of great importance becau

Effects of interferon treatment on liver
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation
✍ R. Todd Stravitz; Mitchell L. Shiffman; Arun J. Sanyal; Velimir A. Luketic; Rich πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 938 KB

Recurrent hepatitis C after liver transplantation remains a significant cause of graft loss and retransplantation. Although treatment of recurrent hepatitis C with interferon-based regimens has become widely accepted as safe and can lead to sustained virologic clearance of hepatitis C virus (HCV) RN